{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_018659.4:c.1190A>G",
          "cDNA Change": {
            "transcript": "NM_018659.4",
            "ref": "A",
            "alt": "G",
            "position": "1190"
          },
          "Protein Change": {
            "ref": "H",
            "alt": "R",
            "position": "387"
          },
          "Description in input context": "c.1190A>G (p.H387R)"
        },
        {
          "HGVS": "NM_018659.4:c.1645G>C",
          "cDNA Change": {
            "transcript": "NM_018659.4",
            "ref": "G",
            "alt": "C",
            "position": "1645"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "549"
          },
          "Description in input context": "c.1645G>C (p.A549P)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0001721"
  },
  "Experiment Method": [
    {
      "Assay Method": "siRNA knockdown/overexpression combined with Western blot and cell viability assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y cells",
        "Description": "The experiment was conducted using the SH-SY5Y neuroblastoma cell line."
      },
      "Readout type": "Quantitative and Qualitative",
      "Readout description": [
        {
          "Variant": "NM_018659.4:c.1190A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased kinase activity and reduced cell viability observed for the c.1190A>G variant."
        },
        {
          "Variant": "NM_018659.4:c.1645G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased kinase activity and reduced cell viability observed for the c.1645G>C variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels within 10-20% of wild-type controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression levels exceeding 50% increase or decrease compared to wild-type controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}